Candriam SCA’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,504
| Closed | -$3.29M | – | 685 |
|
|
2025
Q1 | $3.29M | Sell |
13,504
-20,243
| -60% | -$6.09M | 0.02% | 409 |
|
|
2024
Q4 | $11.1M | Buy |
33,747
+2,220
| +7% | +$754K | 0.06% | 248 |
|
|
2024
Q3 | $10.5M | Buy |
31,527
+8,153
| +35% | +$2.59M | 0.06% | 267 |
|
|
2024
Q2 | $6.38M | Sell |
23,374
-36,284
| -61% | -$10.6M | 0.04% | 308 |
|
|
2024
Q1 | $20.6M | Sell |
59,658
-39,666
| -40% | -$13M | 0.13% | 163 |
|
|
2023
Q4 | $32.1M | Buy |
99,324
+26,202
| +36% | +$8.21M | 0.22% | 102 |
|
|
2023
Q3 | $26.2M | Sell |
73,122
-18,869
| -21% | -$7.28M | 0.19% | 111 |
|
|
2023
Q2 | $34.9M | Buy |
91,991
+7,916
| +9% | +$3.22M | 0.25% | 95 |
|
|
2023
Q1 | $37.1M | Sell |
84,075
-2,403
| -3% | -$1.12M | 0.26% | 91 |
|
|
2022
Q4 | $36.4M | Sell |
86,478
-9,157
| -10% | -$3.7M | 0.25% | 94 |
|
|
2022
Q3 | $39.9M | Buy |
95,635
+25,352
| +36% | +$12.6M | 0.28% | 81 |
|
|
2022
Q2 | $34.8M | Sell |
70,283
-407
| -0.6% | -$212K | 0.29% | 86 |
|
|
2022
Q1 | $39.8M | Buy |
70,690
+11,652
| +20% | +$7.02M | 0.27% | 88 |
|
|
2021
Q4 | $44.6M | Buy |
59,038
+14,195
| +32% | +$10.6M | 0.28% | 86 |
|
|
2021
Q3 | $33.4M | Sell |
44,843
-12,415
| -22% | -$9.3M | 0.23% | 104 |
|
|
2021
Q2 | $36.9M | Sell |
57,258
-73,514
| -56% | -$44.7M | 0.25% | 94 |
|
|
2021
Q1 | $73.2M | Sell |
130,772
-3
| -0% | -$1.78K | 0.61% | 32 |
|
|
2020
Q4 | $76.2M | Buy |
130,775
+7,523
| +6% | +$4.28M | 0.6% | 32 |
|
|
2020
Q3 | $63.5M | Buy |
123,252
+20,107
| +19% | +$10.2M | 0.6% | 32 |
|
|
2020
Q2 | $46.6M | Buy |
103,145
+23,644
| +30% | +$10.4M | 0.49% | 40 |
|
|
2020
Q1 | $28.8M | Buy |
79,501
+7
| +0% | +$2.57K | 0.32% | 62 |
|
|
2019
Q4 | $29.4M | Buy |
79,494
+11,044
| +16% | +$3.89M | 0.32% | 62 |
|
|
2019
Q3 | $22.8M | Buy |
68,450
+23,660
| +53% | +$7.72M | 0.3% | 65 |
|
|
2019
Q2 | $13.9M | Buy |
44,790
+1,500
| +3% | +$449K | 0.17% | 139 |
|
|
2019
Q1 | $13.2M | Hold |
43,290
| – | – | 0.17% | 139 |
|
|
2018
Q4 | $10.1M | Buy |
43,290
+7,040
| +19% | +$1.89M | 0.15% | 156 |
|
|
2018
Q3 | $11.3M | Buy |
36,250
+15,850
| +78% | +$4.92M | 0.15% | 169 |
|
|
2018
Q2 | $5.89M | Buy |
20,400
+2,900
| +17% | +$801K | 0.09% | 266 |
|
|
2018
Q1 | $4.38M | Buy |
17,500
+9,000
| +106% | +$2.29M | 0.07% | 307 |
|
|
2017
Q4 | $2.03M | Buy |
+8,500
| New | +$2.06M | 0.04% | 450 |
|
|
2017
Q3 | – | Sell |
-9,500
| Closed | -$2.15M | – | 727 |
|
|
2017
Q2 | $2.15M | Hold |
9,500
| – | – | 0.04% | 448 |
|
|
2017
Q1 | $1.89M | Hold |
9,500
| – | – | 0.04% | 457 |
|
|
2016
Q4 | $1.73M | Buy |
+9,500
| New | +$1.62M | 0.04% | 395 |
|
|
2015
Q1 | – | Sell |
-38,000
| Closed | -$4.58M | – | 640 |
|
|
2014
Q4 | $4.58M | Buy |
+38,000
| New | +$4.37M | 0.1% | 248 |
|
Other funds holding BIO
VAM
AI
FPA